Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Modeling implementation of early infant male circumcision in Rwanda: Lessons learnt


5th World Congress on Virology

December 07-09, 2015 Atlanta, USA

Chaste Karangwa

Rwanda Biomedical Center, Rwanda

Scientific Tracks Abstracts: J Antivir Antiretrovir

Abstract :

Background: Medical male circumcision (MMC) has been proven to reduce the risk of HIV infection in men. Rwanda does not traditionally circumcise, after sensitization campaigns through community people were interested in MMC, to meet this demandadult MMCisprovided since 2008, in additionRwanda is modeling Newborn male circumcision (performed between births to 2 months) as long term strategy. Methodology: A steering committee was established to oversee implementation and to review progress regularly. Steps in establishing the services followed the classical program cycle of assessment, planning, implementation and monitoring. Medical staff from maternity and surgical department was trained on Mogen device use for 3 days, sites were selected, supplies were procured, and clients were sensitized and enrolled. Data and adverse events was collected routinely and reviewed for uptake improvement. Results: A total of 85 circumcisions were performed, 6% of these consented at the ANC, 35% after delivery and 59% during routine child welfare clinic visits.The average birth weight was 3.3 kilos and age was 41 days.Majority (n/N) did not experience any adverse events (AE), five experienced AE such as bleeding and 8 had incomplete removal of the foreskin. Lessons learned & next steps: Integration of newborn male circumcision in MNCH setting is feasible. Mogen clamp is simple to use. Selection of health care workers with surgical experience, extended and adequate training using infant penis models and supervision on the job are critical to minimize AE and to achieve better outcome of Newborn male circumcision procedures.

Biography :

Chaste Karangwa is an MSc candidate, working with Rwanda Biomedical Centre as HIV biomedical prevention specialist within prevention unit. He is in charge of coordinating all biomedical prevention activities (male circumcision and prevention with positive) and also experienced in HIV data management (demand and use). He has published 2 papers in HIV international conferences.

Email: kchaste92@gmail.com

Top